drugset / Trial / NCT00700583
Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men
NaSingle-groupOpen-labelTreatment
Summary
The aim of the present study was to determine whether the combined administration of a diuretic agent, hydrochlorothiazide, at night would improve the frequency of nocturia unresponsive to alpha-blocker monotherapy in men with LUTS.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 25 mg | — |
| Background | Terazosin | Small molecule | 4 mg | — |
Indications
No indication recorded.